Medtronic plc

Listed Company

MDTCIK 0001613103NYSELarge AcceleratedElectromedical & Electrotherapeutic ApparatusFY ends Apr 24

Period

FY 2026

Revenue

$36.36B

Net Income

$4.80B

Total Assets

$93.03B

Equity

$49.46B

Shares Out

1.28B

Op. Cash Flow

$7.33B

MDT$83.18−7.11% · past yearDBEQ Basic

Daily closing prices

Business

Medtronic plc is a global healthcare technology company that develops, manufactures, and distributes device-based medical therapies and services. The company offers implantable cardiac devices, neurostimulation systems, surgical instruments, monitoring products, and diabetes management solutions across three reportable segments: Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. Medtronic serves healthcare systems, physicians, and patients in more than 150 countries through direct sales representatives and third-party distributors.

Summary from 10-K filed 2026-06-18

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2026 2026-04-30	FY 2025 2025-04-30	FY 2024 2024-04-30	FY 2023 2023-04-30	FY 2022 2022-04-30
Net sales	36,364	33,537	32,364	31,227	31,686
Cost of products sold, excluding amortization of intangible assets	12,721	11,632	11,216	10,719	10,145
Research and development expense	2,873	2,732	2,735	2,696	2,746
Selling, general, and administrative expense	11,784	10,849	10,736	10,415	10,292
Amortization of intangible assets	1,800	1,800	1,700	1,700	1,700
Restructuring charges, net	249	267	226	375	60
Certain litigation charges, net	113	317	149	—	—
Other operating expense (income), net	386	−23	464	−131	862
Operating profit	6,467	5,955	5,144	5,485	5,752
Other non-operating expense (income), net	−384	−402	−412	−515	−318
Interest expense, net	715	729	719	636	—
Income before income taxes	6,136	5,628	4,837	5,364	5,517
Income tax provision	1,299	936	1,133	1,580	456
Net income	4,837	4,691	3,705	3,784	5,062
Net income attributable to noncontrolling interests	−37	−29	−28	−26	−22
Net income attributable to Medtronic	4,801	4,662	3,676	3,758	5,039
Basic earnings per share (in dollars per share)	3.75	3.63	2.77	2.83	3.75
Diluted earnings per share (in dollars per share)	3.73	3.61	2.76	2.82	3.73
Basic weighted average shares outstanding (in shares)	1,282	1,286	1,328	1,330	1,342
Diluted weighted average shares outstanding (in shares)	1,288	1,290	1,330	1,333	1,351

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2026 2026-04-30	FY 2025 2025-04-30	FY 2024 2024-04-30	FY 2023 2023-04-30	FY 2022 2022-04-30
Cash and cash equivalents	1,949	2,218	1,284	1,543	3,714
Investments	7,271	6,747	6,721	6,416	6,859
Accounts receivable, less allowance for credit losses of $190 and $199, respectively	6,643	6,515	6,128	5,998	5,551
Inventories	5,951	5,476	5,217	5,293	4,616
Other current assets	2,972	2,858	2,584	2,425	2,318
Total current assets	24,787	23,814	21,935	21,675	23,059
Property, plant, and equipment, net	7,417	6,837	6,131	5,569	—
Goodwill	42,587	41,737	40,986	41,425	40,502
Other intangible assets, net	10,146	11,667	13,225	14,844	15,595
Tax assets	3,943	4,040	3,657	3,477	3,403
Other assets	4,147	3,584	4,047	3,959	3,008
Total assets	93,028	91,680	89,981	90,948	90,981
Current debt obligations	1,788	2,874	1,092	20	3,742
Accounts payable	2,644	2,449	2,410	2,662	2,276
Accrued compensation	2,678	2,514	2,375	1,949	2,121
Accrued income taxes	914	1,358	1,330	840	704
Other accrued expenses	3,634	3,683	3,582	3,581	3,551
Total current liabilities	11,658	12,879	10,789	9,051	12,394
Long-term debt	26,173	25,642	23,932	24,344	20,372
Accrued compensation and retirement benefits	1,193	1,158	1,101	1,093	1,113
Accrued income taxes	1,515	1,574	1,859	2,360	2,087
Deferred tax liabilities	362	403	515	708	884
Other liabilities	2,055	1,769	1,365	1,727	1,410
Total liabilities	42,956	43,424	39,561	39,283	38,260
Commitments and contingencies (Notes 3, 16, and 18)	—	—	—	—	—
Ordinary shares par value $0.0001, 2.6 billion shares authorized, 1,280,177,293 and 1,281,934,628 shares issued and outstanding, respectively	0	0	0	0	0
Additional paid-in capital	20,926	20,833	23,129	24,590	24,566
Retained earnings	32,638	31,476	30,403	30,392	30,250
Accumulated other comprehensive loss	−4,101	−4,284	−3,318	−3,499	−2,265
Total shareholders equity	49,463	48,024	50,214	51,483	52,551
Noncontrolling interests	609	232	206	182	171
Total equity	50,072	48,256	50,420	51,665	52,722
Total liabilities and equity	93,028	91,680	89,981	90,948	90,981

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2026 2026-04-30	FY 2025 2025-04-30	FY 2024 2024-04-30	FY 2023 2023-04-30	FY 2022 2022-04-30
Depreciation and amortization	2,958	2,861	2,647	2,697	2,707
Provision for credit losses	136	123	90	73	58
Deferred income taxes	51	−316	−508	−226	−604
Stock-based compensation	457	429	393	355	359
Asset impairments and related inventory write-downs	0	0	371	0	515
Other, net	314	310	573	270	138
Accounts receivable, net	−200	−433	−391	−576	−477
Inventories	−404	−292	−139	−939	−560
Accounts payable and accrued liabilities	46	209	391	696	213
Other operating assets and liabilities	−865	−538	−345	−148	−65
Net cash provided by operating activities	7,330	7,044	6,787	6,039	7,346
Acquisitions, net of cash acquired	−406	−98	−211	−1,867	−91
Additions to property, plant, and equipment	−1,904	−1,859	−1,587	−1,459	−1,368
Purchases of investments	−8,725	−8,226	−7,748	−7,514	−9,882
Sales and maturities of investments	8,105	8,495	7,441	7,343	9,692
Other investing activities, net	−4	−249	−261	4	−10
Net cash used in investing activities	−2,934	−1,937	−2,366	−3,493	−1,659
Change in current debt obligations, net	9	−1,070	1,073	0	0
Issuance of long-term debt	1,747	3,209	0	5,409	0
Payments on long-term debt	−2,930	0	0	−6,012	−1
Dividends to shareholders	−3,639	−3,589	−3,666	−3,616	−3,383
Issuance of ordinary shares	516	508	284	—	—
Repurchase of ordinary shares	−1,035	−3,235	−2,138	−645	−2,544
Proceeds from MiniMed initial public offering	538	0	0	—	—
Other financing activities, net	44	−184	−3	−409	163
Net cash used in financing activities	−4,751	−4,361	−4,450	−4,960	−5,336
Effect of exchange rate changes on cash and cash equivalents	85	188	−230	243	−231
Net change in cash and cash equivalents	−269	934	−259	−2,171	121
Income taxes	1,942	1,819	1,622	1,548	996
Interest	774	762	826	606	540

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro

Frequently asked questions

What is Medtronic plc's CIK number?

Medtronic plc's SEC CIK number is 0001613103 (1613103). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.

Where can I find Medtronic plc's SEC filings?

All of Medtronic plc's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.

When did Medtronic plc last report earnings?

Medtronic plc (MDT) most recently filed an earnings 8-K with the SEC on Jun 3, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001628280-26-040034). This is Medtronic plc's most recent earnings filing of record — not a forecast of its next earnings date.

What is Medtronic plc's most recent earnings 8-K?

Medtronic plc's latest earnings 8-K (Item 2.02) was filed Jun 3, 2026 under accession 0001628280-26-040034. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.

View Medtronic plc's latest earnings 8-K →
Look up any company's CIK number →